Philipp Sander,
| Scripps Research Institute | # of Grants: 1 |
Grants
| Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment | 2019 (Cycle 30) | $118,350 |
| Cancer | Dissertation Awards | |
Publications
| Research Portfolio |
| Funding Opportunities |
| Scripps Research Institute | # of Grants: 1 |
| Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment | 2019 (Cycle 30) | $118,350 |
| Cancer | Dissertation Awards | |